NONOF:OTCMKTS
Novo Nordisk A/S
42,42 US$
arrow_downward
-2,87%(-1,25) 1D
15 სექ, 16:00:00 GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NONOF...
Open
42,21 US$
High
43,26 US$
Low
41,94 US$
Mkt. cap
144,39 მლრ.
Avg. vol.
114,28 ათ.
Volume
225,26 ათ.
52-wk high
64,75 US$
52-wk low
34,00 US$
Beta
0,63
Shares outstanding
3,39 მლრდ.
No. of employees
67 ათ.
Open
42,21 US$
High
43,26 US$
Low
41,94 US$
Mkt. cap
144,39 მლრ.
Avg. vol.
114,28 ათ.
Volume
225,26 ათ.
52-wk high
64,75 US$
52-wk low
34,00 US$
Beta
0,63
Shares outstanding
3,39 მლრდ.
No. of employees
67 ათ.
News stories
From web sources and news partners
TradingView
·
5 საათის წინ
Novo Nordisk Stock Falls After Major Rebrand
The Motley Fool
·
7 საათის წინ
Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
Stock Titan
·
10 საათის წინ
Novo Nordisk (NYSE: NVO) has repurchased 33,084,179 shares
MedWatch
·
12 საათის წინ
German investment bank forecasts strong demand for Eli Lilly's weight-loss drugs
Profile
Novo is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority of its voting shares.
Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices.
Novo employs more than 48,000 people globally, and markets its products in 168 countries. The corporation was created in 1989, through a merger of two Danish companies, which date back to the 1920s. Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights, while spin-off company Novozymes was named fourth. It is a leader in the FTSE4Good Index, and the only European company in the top ten. Novo is the largest pharmaceutical company in Denmark. Wikipedia
About Novo Nordisk A/S
CEOმაზიარ მაიკ დუსტარ
Employees66,7 ათ.
Founded21 დეკ. 1923
HeadquartersBagsværd, დედაქალაქის რეგიონი, დანია
SectorPharmaceutical industry
Websitenovonordisk.com